NICHOLA WARNECKE: Open Payments
NPI 1376824086 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,219 in 134 payments from 21 companies in 2025. Trend: 2023 $10,395 · 2024 $7,184 · 2025 $7,219
Speaker / faculty: $4,725Food & beverage: $2,494
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $5,390 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $383 |
| Janssen Biotech, Inc. | 11 | $266 |
| PFIZER INC. | 9 | $193 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $185 |
| Gilead Sciences, Inc. | 7 | $142 |
| Ardelyx, Inc. | 6 | $122 |
| QOL Medical, LLC | 4 | $84 |
| Madrigal Pharmaceuticals | 5 | $74 |
| Aimmune Therapeutics, Inc. | 4 | $65 |
Products named: LINZESS, CREON, ENTYVIO, TREMFYA, SKYRIZI, XIFAXAN, IBSRELA, XELJANZ.
Industry payments across OH — which companies pay providers there.
